Search results for: 'parc paas analysis for laboratory develop'

In the cloud market, as well as in most other technology markets, 2024 will be all about artificial intelligence (AI). Businesses across industries are scrambling to determine how they can leverage AI and, particularly, generative AI to meet their business goals. Public cloud providers are at the forefront of the effort to accelerate AI adoption am...

The COVID-19 pandemic accelerated the shift toward greater adoption of decentralized healthcare, building trust by demonstrating the feasibility and ease of testing at home and in pharmacies with accurate results, including self-sampling options. Increasing technological advancements have created several opportunities for market expansion in direct...

The purpose of this study is to provide a general overview of the regulatory frameworks that shape the commercial drone industry and how global events have impacted the evolution of these regulations in the last few years. Mandatory use of remote ID technology on drone platforms is one of the primary regulatory changes. Drone manufacturers in th...

The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...

The increasing prevalence of lifestyle diseases such as diabetes and obesity, coupled with a growing consumer inclination towards healthy lifestyles, are driving the demand for no- or low-calorie food products and, in consequence, the growth of the global alternative sweetener market. Additionally, the growing beverage market in both developed and ...

The development of augmented reality (AR), virtual reality (VR), and extended reality (XR) technologies expect to accelerate in upcoming years. Technology developers and adopters across various industries experiment with these innovations for mass deployment, driving the shift from product testing for specific application requirements to scaling th...

The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...

The procedure for accurately identifying a biomarker correlation based on a patient s genetic makeup is complex and relies on the expertise and knowledge of an oncologist, decision-support scientist, or other healthcare professional involved in the matching process. Precision oncology aims to provide oncologists with diagnosis, prognosis, and treat...

This research consists of an analysis of developments in biosensors